Detalhe da pesquisa
1.
Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapy.
J Hepatol
; 77(4): 967-977, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35714812
2.
First-Time-in-Human Study and Prediction of Early Bactericidal Activity for GSK3036656, a Potent Leucyl-tRNA Synthetase Inhibitor for Tuberculosis Treatment.
Antimicrob Agents Chemother
; 63(8)2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31182528
3.
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial.
Nat Med
; 30(3): 896-904, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38365949
4.
Deformation of 1-piece metal acetabular components.
J Arthroplasty
; 27(1): 48-54, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21641760
5.
A Randomized, Double-Blind, Placebo-Controlled, First-Time-in-Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of GSK3389404 in Healthy Subjects.
Clin Pharmacol Drug Dev
; 8(6): 790-801, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30861337
6.
Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Neurol
; 16(3): 208-216, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28139349
7.
An adaptive design to investigate the effect of ketoconazole on pharmacokinetics of GSK239512 in healthy male volunteers.
J Clin Pharmacol
; 55(5): 505-11, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25470032
8.
Inner-city gunshot wounds10 years on.
Injury
; 42(5): 488-91, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21035800